Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval To Begin Clinical Trials Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that its affiliate VGX International Inc. (Korean Stock Exchange: 011000) has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza. Inovio is co-developing VGX-3400 ... [News Source]

Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval To Begin Clinical Trials (Medical News Today) Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that its affiliate VGX International Inc. (Korean Stock Exchange: 011000) has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza. Inovio is co-developing VGX-3400 ... [News Source]

Vietnam reports two new human cases of bird flu (EARTHtimes.org) Hanoi - Vietnamese authorities announced two new human cases of avian influenza Wednesday, the second and third this year. Nguyen Huy Nga, head of the Health Ministry's preventive medicine and environment department, said the latest cases were a 17-y... [News Source]

Bird flu outbreak strikes Khanh Hoa (Vietnam Net) VietNamNet Bridge – A fresh outbreak of avian flu (A/H5N1) has been reported in central Khanh Hoa Province, killing nearly 10,000 birds. Affected areas have been decontaminated and poultry incinerated, said a spokesperson from the provincial Animal Health Unit. [News Source]